FDA Approves First Systemic Treatment Olumiant (Baricitinib) for Alopecia Areata
Summary : The U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a…
Summary : The U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a…
Summary : IMCIVREE now available for chronic weight management in adult and pediatric patients 6 years of age and older with monogenic…
Summary : Amvuttra (vutrisiran) from Alnylam Pharmaceuticals has been licenced by the US Food and Drug Administration for the treatment of hereditary…
Summary : Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNI™ (rituximab-arrx), a biosimilar to Rituxan®, in…
Summary : Camzyos (mavacamten), the first FDA-approved cardiac myosin inhibitor that directly addresses the root of obstructive hypertrophic cardiomyopathy, has been authorised…
Summary : HYFTOR™ is the first topical treatment approved by the FDA for facial angiofibroma in individuals with tuberous sclerosis complex (TSC) 6…
Summary : The Venus VivaTM will now make its American premiere, having already established itself as a pioneer in the worldwide medical…
Summary: EPSOLAY (benzoyl peroxide, cream, 5%) utilizes Sol-Gel’s proprietary microencapsulation technology for the treatment of inflammatory lesions of rosacea and is patent…
Summary : The first treatment for COVID-19 in young children has been approved by the US Food and Drug Administration. In this…
Synopsis : Under the terms of the agreement, Pfizer will acquire ReViral for a total consideration of up to $525 million, including…